AD, brachydactyly, type A2; AD, short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies; AR HFE hemochromatosis, modifier of.
PP3, BS4
GLI3
c.3746G > A, p.C1249Y
P (1.000)
B (0.000)
T (1.000)
—
0.00006
0.00005
Somatic, hypothalamic hamartomas; AD, Greig cephalopolysyndactyly syndrome; AD, Pallister-Hall syndrome; AD, polydactyly, postaxial, types A1 and B; AD, polydactyly, preaxial, type IV.
BS4, BP4
CHD7
c.2496C > G, p.N832K
D (1.000)
D (0.900)
D (0.002)
—
—
0.00000
AD, CHARGE syndrome; AD, hypogonadotropic hypogonadism 5 with or without anosmia
PM2, PP3, BS4
MYH9
c.4872_4876delinsTCACG, p.I1626V
D (0.840)
B (0.041)
—
—
—
—
AD, deafness, autosomal dominant 17; AD, macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss